Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/4551
Full metadata record
DC FieldValueLanguage
dc.contributor.authorM Akhila-
dc.date.accessioned2026-05-20T06:57:31Z-
dc.date.available2026-05-20T06:57:31Z-
dc.date.issued2026-05-20-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/4551-
dc.descriptionVol21, No.2 , p 8en_US
dc.language.isoenen_US
dc.subjectOvarian canceren_US
dc.subjectDNA damage responseen_US
dc.subjectHomologous recombination deficiencyen_US
dc.subjectBRCA mutationsen_US
dc.subjectReplication fork protectionen_US
dc.subjectPrecision oncologyen_US
dc.titlePARP Inhibitor resiatance in overian cancer : mechanisms, biomarkers, and therapentic strategiesen_US
dc.typeOtheren_US
Appears in Collections:Vol21, No.2 , 2026

Files in This Item:
File Description SizeFormat 
1.pdfVol21, No.2 , p 8183.59 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.